文献速递青光眼

青光眼引流装置植入术后三年视野功能评估

Evaluation of Long-Term Visual Field Function in Patients Undergoing Glaucoma Drainage Device Implantation.
PubMed 文献 · Am J Ophthalmol · 2020-03-26

该回顾性介入病例系列纳入2010至2015年接受青光眼引流装置(GDD)植入且有可靠术前及每年术后视野检查的患眼,比较术前与随访的视力、眼压、用药数量及全局与区域Humphrey视野指标。3年随访时平均眼压从23.1±8.5 mmHg降至12.7±3.1 mmHg(P<.001),MD、PSD及全局CIGTS_PDP无显著变化,仅全局CIGTS_TDP从10.7轻度进展至12.8(P=.01),各区域指标均未恶化。

要点

  • GDD术后3年眼压显著下降,整体视野功能基本稳定。
  • 仅全局CIGTS_TDP出现轻度进展,区域视野指标均未恶化。
  • 术前青光眼用药数量与CIGTS_TDP恶化相关。

核心结论

  • GDD手术在3年随访期内总体上有效稳定视野功能,但全局CIGTS_TDP显示轻度进展。

研究设计与样本

  • 回顾性介入病例系列,纳入2010至2015年接受GDD植入且有可靠术前及每年术后视野测量的患眼,共106眼来自95例患者。

主要发现

  • 平均眼压±SD从23.1±8.5 mmHg降至3年随访时12.7±3.1 mmHg(P<.001)。
  • MD、PSD及全局CIGTS_PDP随访期间无显著变化,全局CIGTS_TDP从10.7轻度进展至12.8(P=.01)。
  • 各区域指标在随访检查中均未显示恶化,基线与随访时上半球视野缺损均较下半球更常见。
  • 术前青光眼用药数量与CIGTS_TDP恶化相关。

关键数值与推荐

  • 全局CIGTS_TDP从10.7进展至12.8(P=.01),其余全局及区域视野指标无显著变化。

临床怎么用

  • GDD植入后应长期随访视野,关注上半球视野及CIGTS_TDP变化,并重视术前用药数量较多的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the change in global and regional Humphrey visual fields (VF) after glaucoma drainage device (GDD) implantation over a 3-year follow-up period. DESIGN: Retrospective interventional case series. METHODS: Patients undergoing GDD placement from between 2010 and 2015 with reliable preoperative and yearly postoperative VF measurements were included. Clinical parameters were compared between preoperative and follow-up visits, including visual acuity, intraocular pressure (IOP), number of glaucoma medications, global VF metrics (mean deviation [MD]), pattern standard deviation (PSD), CIGTS (Collaborative Initial Glaucoma Treatment Study) score of total deviation probability (CIGTS_TDP) and pattern deviation probability (CIGTS_PDP), and regional metrics (regional total deviation (TD), regional pattern deviation (PD), and regional CIGTS_TDP and CIGTS_PDP). Multivariate regression analyses were performed to determine risk factors for VF worsening after GDD surgery. RESULTS: A total of 106 eyes from 95 patients were included. Mean IOP ± SD was reduced from 23.1 ± 8.5 mm Hg to 12.7 ± 3.1 mm Hg at 3-year follow-up (P < .001). MD, PSD, and global CIGTS_PDP showed no significant changes in follow-up, whereas global CIGTS_TDP showed mild progression from 10.7 to 12.8 at 3-year follow-up (P = .01). No regional metrics showed worsening at follow-up examinations. Defects in the superior hemifield were more common than in the inferior hemifield at baseline and follow-up examinations for all regional metrics. Pre-operative number of glaucoma medications was associated with worsening on CIGTS_TDP. CONCLUSIONS: Overall, GDD surgery is effective at stabilizing VF function over 3 years of follow-up. The superior hemifield is affected more than other regions. The number of pre-operative glaucoma medications is associated with mild VF progression, measured by CIGTS_TDP.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Liu Q, Saifee M, Yu Y, et al. Evaluation of Long-Term Visual Field Function in Patients Undergoing Glaucoma Drainage Device Implantation. Am J Ophthalmol. 2020. PMID: 32224104. doi:10.1016/j.ajo.2020.03.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。